Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Nature Communications|August 2, 2022
CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newbornsSimon D van Haren, Gabriel K Pedersen, Azad Kumar, et al.
Journal of Virology|September 2, 2016
Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus VectorBo Liang, Joan O Ngwuta, Richard Herbert, et al.
The Journal of Infectious Diseases|August 15, 2018
Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory IllnessNatalie I Mazur, Nicole M Horsley, Janet A Englund, et al.
Science Translational Medicine|October 16, 2015
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human seraJoan O Ngwuta, Man Chen, Kayvon Modjarrad, et al.
Immunity|September 9, 2023
Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumovirusesSebastian Ols, Klara Lenart, Rodrigo Arcoverde Cerveira, et al.
Science (New York, N.Y.)|November 2, 2013
Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virusJason S McLellan, Man Chen, M Gordon Joyce, et al.
The Lancet. Respiratory Medicine|April 17, 2021
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trialTracy J Ruckwardt, Kaitlyn M Morabito, Emily Phung, et al.
Science (New York, N.Y.)|August 3, 2019
A proof of concept for structure-based vaccine design targeting RSV in humansMichelle C Crank, Tracy J Ruckwardt, Man Chen, et al.
Iscience|February 3, 2025
MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodiesOlubukola M Abiona, Nianshuang Wang, Sarah R Leist, et al.
Pageof 4